logo

سوق مراقبة غلوكوز الدم - النمو ، والاتجاهات ، وتأثير كوفيد -19 ، والتوقعات (2022 - 2027)

يتم تقسيم السوق حسب النوع (المراقبة الذاتية لنسبة الجلوكوز في الدم والمراقبة المستمرة للجلوكوز) ، والمكونات (أجهزة قياس السكر ، وشرائط الاختبار ، والمشارط ، وأجهزة الاستشعار ، وأجهزة الاستقبال) ، والجغرافيا.

Home Industry Reports Healthcare سوق مراقبة غلوكوز الدم - النمو ، والاتجاهات ، وتأثير كوفيد -19 ، والتوقعات (2022 ...

لقطة السوق

Blood Glucose Monitoring Market
Study Period: 2016-2027
Base Year: 2021
Fastest Growing Market: North America
Largest Market: North America
CAGR: 9.6 %
Blood Glucose Monitoring Market Growth

Need a report that reflects how COVID-19 has impacted this market and its growth?

نظرة عامة على السوق

من المتوقع أن يسجل سوق مراقبة نسبة الجلوكوز في الدم معدل نمو سنوي مركب قدره 9.6٪ خلال الفترة المتوقعة 2021-2026. تشير التقديرات إلى أن السوق سيصل إلى قيمة 27.2 مليار دولار أمريكي بحلول عام 2026 ، ويرجع ذلك إلى زيادة استخدام أجهزة المراقبة بين مرضى السكري من النوع 2. تستخدم أجهزة مراقبة نسبة الجلوكوز في الدم لتشخيص وعلاج مرض السكري بشكل فعال. يؤدي ارتفاع عدد مرضى السكري إلى دفع السوق من خلال زيادة استخدام أجهزة مراقبة نسبة السكر في الدم. تعتبر السمنة أيضًا أحد العوامل الرئيسية المساهمة في المرض ، وخاصة مرض السكري من النوع 2. كما أن هناك عوامل أخرى ، مثل الابتكارات والتطورات التكنولوجية ، توفر الكثير من الراحة في قياس مستويات السكر في الدم. يتم إنشاء أحد هذه التطورات في مراقبة مستوى الجلوكوز في الدم من خلال أجهزة مراقبة الجلوكوز المستمرة. تساعد هذه الأجهزة في الكشف المبكر عن حالات نقص السكر في الدم وفرط سكر الدم. من المتوقع أن يؤدي هذا الإحسان إلى دفع السوق لمراقبة الجلوكوز.

نطاق التقرير

هناك نوعان رئيسيان من أجهزة مراقبة نسبة الجلوكوز في الدم المدرجة في هذه الدراسة ، وهما أجهزة المراقبة الذاتية لنسبة السكر في الدم ، وأجهزة مراقبة الجلوكوز المستمرة. يتم تصنيف الأجهزة بشكل إضافي حسب المكونات ، أي أجهزة مراقبة السكر في الدم (SMBG) مقسمة إلى أجهزة قياس السكر ، وشرائط الاختبار ، والمشارط ، وأجهزة المراقبة المستمرة للجلوكوز (CGM) مقسمة إلى أجهزة استشعار وأجهزة استقبال.

Self-monitoring blood glucose devices (Value and Volume, 2016 - 2026)
By Component
Glucometer Devices
Test Strips
Lancets
Continuous blood glucose monitoring devices (Value and Volume, 2016 - 2026)
By Component
Sensors
Durables (Receivers and Transmitters)
Geography
North America
United States (Value and Volume, 2016 - 2026)
Self-monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, Lancets)
Continuous Glucose Monitoring devices
By Component (Sensors and Receivers)
Canada (Value and Volume, 2016 - 2026)
Self-monitoring blood glucose devices
By Component (Glucometer Device, Test strips, and Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Receivers)
Rest of North America (Value and Volume, 2016 - 2026)
Self-monitoring blood glucose devices
By Component (Glucometer Device, Test strips, and Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Receivers)
Europe
France (Value and Volume, 2016 - 2026)
Self-monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, and Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Receivers)
Germany (Value and Volume, 2016 - 2026)
Self-monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, and Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Receivers)
Italy (Value and Volume, 2016 - 2026)
Self-monitoring blood glucose devices
By Component (Glucometer Device, Test strips, and Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Receivers)
Spain (Value and Volume, 2016 - 2026)
Self-monitoring blood glucose devices
By Component (Glucometer Device, Test strips, and Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Receivers)
United Kingdom (Value and Volume, 2016 - 2026)
Self-monitoring blood glucose devices
By Component (Glucometer Device, Test strips, and Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Receivers)
Russia (Value and Volume, 2016 - 2026)
Self-monitoring blood glucose devices
By Component (Glucometer Device, Test strips, and Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Receivers)
Rest of Europe (Value and Volume, 2016 - 2026)
Self-monitoring blood glucose devices
By Component (Glucometer Device, Test strips, and Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Receivers)
Latin America
Mexico (Value and Volume, 2016 - 2026)
Self-monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, and Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Receivers)
Brazil (Value and Volume, 2016 - 2026)
Self-monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, and Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Receivers)
Rest of Latin America (Value and Volume, 2016 - 2026)
Self-monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, and Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Receivers)
Asia-Pacific
Japan (Value and Volume, 2016 - 2026)
Self-monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, and Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Receivers)
South Korea (Value and Volume, 2016 - 2026)
Self-monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, and Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Receivers)
China (Value and Volume, 2016 - 2026)
Self-monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, and Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Receivers)
India (Value and Volume, 2016 - 2026)
Self-monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, and Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Receivers)
Australia (Value and Volume, 2016 - 2026)
Self-monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, and Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Receivers)
Vietnam (Value and Volume, 2016 - 2026)
Self-monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, and Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Receivers)
Malaysia (Value and Volume, 2016 - 2026)
Self-monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, and Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Receivers)
Indonesia (Value and Volume, 2016 - 2026)
Self-monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, and Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Receivers)
Philippines (Value and Volume, 2016 - 2026)
Self-monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, and Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Receivers)
Thailand (Value and Volume, 2016 - 2026)
Self-monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, and Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Receivers)
Rest of Asia-Pacific (Value and Volume, 2016 - 2026)
Self-monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, and Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Receivers)
Middle-East and Africa
Saudi Arabia (Value and Volume, 2016 - 2026)
Self-monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, and Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Receivers)
Iran (Value and Volume, 2016 - 2026)
Self-monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, and Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Receivers)
Egypt (Value and Volume, 2016 - 2026)
Self-monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, and Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Receivers)
Oman (Value and Volume, 2016 - 2026)
Self-monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, and Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Receivers)
South Africa (Value and Volume, 2016 - 2026)
Self-monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, and Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Receivers)
Rest of Middle-East and Africa (Value and Volume, 2016 - 2026)
Self-monitoring Blood Glucose Devices
By Component (Glucometer Device, Test strips, and Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Receivers)

Report scope can be customized per your requirements. Click here.

اتجاهات السوق الرئيسية

المواد الاستهلاكية غلوكمتر تحتل أعلى حصة في السوق

على الرغم من أن المراقبة المستمرة للسكري هي طريقة متقدمة للأشخاص الذين يعانون من مرض السكري للتحقق من قراءات الجلوكوز في الوقت الفعلي ، إلا أن SMBG هو الجهاز المفضل لدى المرضى نظرًا لقدرته الاقتصادية على تحمل التكاليف واستخدامه الأقل تعقيدًا عند مقارنته بـ CGM. تشغل أجهزة SBGM أكثر من 68٪ من حصة سوق مراقبة نسبة السكر في الدم. من المتوقع أن يكون النمو في حجم السوق وحصة شرائط الاختبار أعلى من تلك الخاصة بأجهزة قياس الجلوكوز ، بسبب الاختلاف في تكرار حالة الاستخدام. يتراوح متوسط ​​كفاءة جهاز قياس نسبة السكر في الدم بين ستة أشهر إلى ثلاث سنوات ، في حين أن شرائط الاختبار تستخدم لمرة واحدة. من المتوقع أن يساعد إدخال أنواع جديدة من أجهزة الوخز التي تسبب ألمًا أقل للمستخدمين على نمو السوق ، حيث من المتوقع أن يرتفع معدل القبول خلال فترة التنبؤ.

Blood Glucose Monitoring Market Trends

أمريكا الشمالية هي الرائدة في السوق

في عام 2020 ، احتلت أمريكا الشمالية ، وخاصة الولايات المتحدة ، الحصة الأكبر من الدم سوق مراقبة الجلوكوز ، بسبب تجمع المرضى الكبير والقبول الواسع للتقنيات المتقدمة التي تتبعها أوروبا ، مع نمو معتدل. وفقًا لجمعية السكري الأمريكية (ADA) ، في عام 2018 ، كان 34.2 مليون أمريكي ، أو 10.5 ٪ من السكان ، يعانون من مرض السكري. ما يقرب من 1.6 مليون أمريكي يعانون من مرض السكري من النوع الأول ، بما في ذلك حوالي 187000 طفل ومراهق. في الولايات المتحدة ، هناك ابتكارات جديدة من الشركات الناشئة التي لديها ما يقرب من 2.9 مليار تمويل في صناعات مرض السكري ، مثل Glooko و OneDrop و verily و Vacate و Insulet و Noom و Bigfoot Biomedical و Virta Health و Diabeloop و Orgenesis وغيرها والشركات انضموا معًا في مجال مرض السكري لجلب تقنيات جديدة إلى زيادة السوق في فترة التنبؤ ، على سبيل المثال ، في يوليو 2020 ، Medtronic PLC و Tandem Diabetes Care Inc.

Blood Glucose Monitoring Market Size

مشهد تنافسي

سوق مراقبة نسبة الجلوكوز في الدم مجزأ للغاية ، مع وجود عدد قليل من الشركات المصنعة الكبرى في السوق. ساعدت عمليات الاندماج والاستحواذ بين اللاعبين في الماضي القريب الشركات على تعزيز وجودها في السوق. على سبيل المثال ، في سبتمبر 2020 ، أعلنت شركة Insulet Corporation ، من خلال نظام إدارة الأنسولين Omnipod (نظام Omnipod) ، أنها ستطلق تجاريًا نظام إدارة الأنسولين Omnipod DASH (نظام Omnipod DASH) في بلدان أخرى. يتوفر نظام Omnipod DASH الآن في السويد وفنلندا والنرويج والدنمارك وسيتم تقديمه في فرنسا وبلجيكا وألمانيا والنمسا وسويسرا وإسرائيل في الأسابيع المقبلة.

Abbott Diabetes Care, Roche Holding AG, LifeScan, Dexcom Inc., Medtronic PLC, Arkray Inc., Ascensia Diabetes Care, Agamatrix Inc.

RECENT DEVELOPMENTS

In Feb 2021, Roche announced the launch of the new Accu-Chek Instant system, a new "connected" blood glucose monitoring (BGM) system, which supports and enables Roche’s approach of integrated Personalised Diabetes Management (iPDM). Accu-Chek Instant features Bluetooth-enabled connectivity to the mySugr app, allowing wireless transfer of blood glucose results to the mySugr app.

In Aug 2021, HAGAR, the developer of GWave technology that uses RF waves to measure glucose levels in the blood. HAGAR announced a USD 11.7 million Series B funding round led by a returning investor, Columbia Pacific. This round’s funding will be used for upcoming trials for Federal Drug Administration (FDA) approval, it will also be used for completing international patents.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Drivers

    3. 4.3 Restraints

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Bargaining Power of Suppliers

      2. 4.4.2 Bargaining Power of Consumers

      3. 4.4.3 Threat of New Entrants

      4. 4.4.4 Threat of Substitute Products and Services

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 Self-monitoring blood glucose devices (Value and Volume, 2016 - 2026)

      1. 5.1.1 By Component

        1. 5.1.1.1 Glucometer Devices

        2. 5.1.1.2 Test Strips

        3. 5.1.1.3 Lancets

    2. 5.2 Continuous blood glucose monitoring devices (Value and Volume, 2016 - 2026)

      1. 5.2.1 By Component

        1. 5.2.1.1 Sensors

        2. 5.2.1.2 Durables (Receivers and Transmitters)

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States (Value and Volume, 2016 - 2026)

          1. 5.3.1.1.1 Self-monitoring Blood Glucose Devices

            1. 5.3.1.1.1.1 By Component (Glucometer Device, Test strips, Lancets)

          2. 5.3.1.1.2 Continuous Glucose Monitoring devices

            1. 5.3.1.1.2.1 By Component (Sensors and Receivers)

        2. 5.3.1.2 Canada (Value and Volume, 2016 - 2026)

          1. 5.3.1.2.1 Self-monitoring blood glucose devices

            1. 5.3.1.2.1.1 By Component (Glucometer Device, Test strips, and Lancets)

          2. 5.3.1.2.2 Continuous Glucose Monitoring

            1. 5.3.1.2.2.1 By Component (Sensors and Receivers)

        3. 5.3.1.3 Rest of North America (Value and Volume, 2016 - 2026)

          1. 5.3.1.3.1 Self-monitoring blood glucose devices

            1. 5.3.1.3.1.1 By Component (Glucometer Device, Test strips, and Lancets)

          2. 5.3.1.3.2 Continuous Glucose Monitoring

            1. 5.3.1.3.2.1 By Component (Sensors and Receivers)

      2. 5.3.2 Europe

        1. 5.3.2.1 France (Value and Volume, 2016 - 2026)

          1. 5.3.2.1.1 Self-monitoring Blood Glucose Devices

            1. 5.3.2.1.1.1 By Component (Glucometer Device, Test strips, and Lancets)

          2. 5.3.2.1.2 Continuous Glucose Monitoring

            1. 5.3.2.1.2.1 By Component (Sensors and Receivers)

        2. 5.3.2.2 Germany (Value and Volume, 2016 - 2026)

          1. 5.3.2.2.1 Self-monitoring Blood Glucose Devices

            1. 5.3.2.2.1.1 By Component (Glucometer Device, Test strips, and Lancets)

          2. 5.3.2.2.2 Continuous Glucose Monitoring

            1. 5.3.2.2.2.1 By Component (Sensors and Receivers)

        3. 5.3.2.3 Italy (Value and Volume, 2016 - 2026)

          1. 5.3.2.3.1 Self-monitoring blood glucose devices

            1. 5.3.2.3.1.1 By Component (Glucometer Device, Test strips, and Lancets)

          2. 5.3.2.3.2 Continuous Glucose Monitoring

            1. 5.3.2.3.2.1 By Component (Sensors and Receivers)

        4. 5.3.2.4 Spain (Value and Volume, 2016 - 2026)

          1. 5.3.2.4.1 Self-monitoring blood glucose devices

            1. 5.3.2.4.1.1 By Component (Glucometer Device, Test strips, and Lancets)

          2. 5.3.2.4.2 Continuous Glucose Monitoring

            1. 5.3.2.4.2.1 By Component (Sensors and Receivers)

        5. 5.3.2.5 United Kingdom (Value and Volume, 2016 - 2026)

          1. 5.3.2.5.1 Self-monitoring blood glucose devices

            1. 5.3.2.5.1.1 By Component (Glucometer Device, Test strips, and Lancets)

          2. 5.3.2.5.2 Continuous Glucose Monitoring

            1. 5.3.2.5.2.1 By Component (Sensors and Receivers)

        6. 5.3.2.6 Russia (Value and Volume, 2016 - 2026)

          1. 5.3.2.6.1 Self-monitoring blood glucose devices

            1. 5.3.2.6.1.1 By Component (Glucometer Device, Test strips, and Lancets)

          2. 5.3.2.6.2 Continuous Glucose Monitoring

            1. 5.3.2.6.2.1 By Component (Sensors and Receivers)

        7. 5.3.2.7 Rest of Europe (Value and Volume, 2016 - 2026)

          1. 5.3.2.7.1 Self-monitoring blood glucose devices

            1. 5.3.2.7.1.1 By Component (Glucometer Device, Test strips, and Lancets)

          2. 5.3.2.7.2 Continuous Glucose Monitoring

            1. 5.3.2.7.2.1 By Component (Sensors and Receivers)

      3. 5.3.3 Latin America

        1. 5.3.3.1 Mexico (Value and Volume, 2016 - 2026)

          1. 5.3.3.1.1 Self-monitoring Blood Glucose Devices

            1. 5.3.3.1.1.1 By Component (Glucometer Device, Test strips, and Lancets)

          2. 5.3.3.1.2 Continuous Glucose Monitoring

            1. 5.3.3.1.2.1 By Component (Sensors and Receivers)

        2. 5.3.3.2 Brazil (Value and Volume, 2016 - 2026)

          1. 5.3.3.2.1 Self-monitoring Blood Glucose Devices

            1. 5.3.3.2.1.1 By Component (Glucometer Device, Test strips, and Lancets)

          2. 5.3.3.2.2 Continuous Glucose Monitoring

            1. 5.3.3.2.2.1 By Component (Sensors and Receivers)

        3. 5.3.3.3 Rest of Latin America (Value and Volume, 2016 - 2026)

          1. 5.3.3.3.1 Self-monitoring Blood Glucose Devices

            1. 5.3.3.3.1.1 By Component (Glucometer Device, Test strips, and Lancets)

          2. 5.3.3.3.2 Continuous Glucose Monitoring

            1. 5.3.3.3.2.1 By Component (Sensors and Receivers)

      4. 5.3.4 Asia-Pacific

        1. 5.3.4.1 Japan (Value and Volume, 2016 - 2026)

          1. 5.3.4.1.1 Self-monitoring Blood Glucose Devices

            1. 5.3.4.1.1.1 By Component (Glucometer Device, Test strips, and Lancets)

          2. 5.3.4.1.2 Continuous Glucose Monitoring

            1. 5.3.4.1.2.1 By Component (Sensors and Receivers)

        2. 5.3.4.2 South Korea (Value and Volume, 2016 - 2026)

          1. 5.3.4.2.1 Self-monitoring Blood Glucose Devices

            1. 5.3.4.2.1.1 By Component (Glucometer Device, Test strips, and Lancets)

          2. 5.3.4.2.2 Continuous Glucose Monitoring

            1. 5.3.4.2.2.1 By Component (Sensors and Receivers)

        3. 5.3.4.3 China (Value and Volume, 2016 - 2026)

          1. 5.3.4.3.1 Self-monitoring Blood Glucose Devices

            1. 5.3.4.3.1.1 By Component (Glucometer Device, Test strips, and Lancets)

          2. 5.3.4.3.2 Continuous Glucose Monitoring

            1. 5.3.4.3.2.1 By Component (Sensors and Receivers)

        4. 5.3.4.4 India (Value and Volume, 2016 - 2026)

          1. 5.3.4.4.1 Self-monitoring Blood Glucose Devices

            1. 5.3.4.4.1.1 By Component (Glucometer Device, Test strips, and Lancets)

          2. 5.3.4.4.2 Continuous Glucose Monitoring

            1. 5.3.4.4.2.1 By Component (Sensors and Receivers)

        5. 5.3.4.5 Australia (Value and Volume, 2016 - 2026)

          1. 5.3.4.5.1 Self-monitoring Blood Glucose Devices

            1. 5.3.4.5.1.1 By Component (Glucometer Device, Test strips, and Lancets)

          2. 5.3.4.5.2 Continuous Glucose Monitoring

            1. 5.3.4.5.2.1 By Component (Sensors and Receivers)

        6. 5.3.4.6 Vietnam (Value and Volume, 2016 - 2026)

          1. 5.3.4.6.1 Self-monitoring Blood Glucose Devices

            1. 5.3.4.6.1.1 By Component (Glucometer Device, Test strips, and Lancets)

          2. 5.3.4.6.2 Continuous Glucose Monitoring

            1. 5.3.4.6.2.1 By Component (Sensors and Receivers)

        7. 5.3.4.7 Malaysia (Value and Volume, 2016 - 2026)

          1. 5.3.4.7.1 Self-monitoring Blood Glucose Devices

            1. 5.3.4.7.1.1 By Component (Glucometer Device, Test strips, and Lancets)

          2. 5.3.4.7.2 Continuous Glucose Monitoring

            1. 5.3.4.7.2.1 By Component (Sensors and Receivers)

        8. 5.3.4.8 Indonesia (Value and Volume, 2016 - 2026)

          1. 5.3.4.8.1 Self-monitoring Blood Glucose Devices

            1. 5.3.4.8.1.1 By Component (Glucometer Device, Test strips, and Lancets)

          2. 5.3.4.8.2 Continuous Glucose Monitoring

            1. 5.3.4.8.2.1 By Component (Sensors and Receivers)

        9. 5.3.4.9 Philippines (Value and Volume, 2016 - 2026)

          1. 5.3.4.9.1 Self-monitoring Blood Glucose Devices

            1. 5.3.4.9.1.1 By Component (Glucometer Device, Test strips, and Lancets)

          2. 5.3.4.9.2 Continuous Glucose Monitoring

            1. 5.3.4.9.2.1 By Component (Sensors and Receivers)

        10. 5.3.4.10 Thailand (Value and Volume, 2016 - 2026)

          1. 5.3.4.10.1 Self-monitoring Blood Glucose Devices

            1. 5.3.4.10.1.1 By Component (Glucometer Device, Test strips, and Lancets)

          2. 5.3.4.10.2 Continuous Glucose Monitoring

            1. 5.3.4.10.2.1 By Component (Sensors and Receivers)

        11. 5.3.4.11 Rest of Asia-Pacific (Value and Volume, 2016 - 2026)

          1. 5.3.4.11.1 Self-monitoring Blood Glucose Devices

            1. 5.3.4.11.1.1 By Component (Glucometer Device, Test strips, and Lancets)

          2. 5.3.4.11.2 Continuous Glucose Monitoring

            1. 5.3.4.11.2.1 By Component (Sensors and Receivers)

      5. 5.3.5 Middle-East and Africa

        1. 5.3.5.1 Saudi Arabia (Value and Volume, 2016 - 2026)

          1. 5.3.5.1.1 Self-monitoring Blood Glucose Devices

            1. 5.3.5.1.1.1 By Component (Glucometer Device, Test strips, and Lancets)

          2. 5.3.5.1.2 Continuous Glucose Monitoring

            1. 5.3.5.1.2.1 By Component (Sensors and Receivers)

        2. 5.3.5.2 Iran (Value and Volume, 2016 - 2026)

          1. 5.3.5.2.1 Self-monitoring Blood Glucose Devices

            1. 5.3.5.2.1.1 By Component (Glucometer Device, Test strips, and Lancets)

          2. 5.3.5.2.2 Continuous Glucose Monitoring

            1. 5.3.5.2.2.1 By Component (Sensors and Receivers)

        3. 5.3.5.3 Egypt (Value and Volume, 2016 - 2026)

          1. 5.3.5.3.1 Self-monitoring Blood Glucose Devices

            1. 5.3.5.3.1.1 By Component (Glucometer Device, Test strips, and Lancets)

          2. 5.3.5.3.2 Continuous Glucose Monitoring

            1. 5.3.5.3.2.1 By Component (Sensors and Receivers)

        4. 5.3.5.4 Oman (Value and Volume, 2016 - 2026)

          1. 5.3.5.4.1 Self-monitoring Blood Glucose Devices

            1. 5.3.5.4.1.1 By Component (Glucometer Device, Test strips, and Lancets)

          2. 5.3.5.4.2 Continuous Glucose Monitoring

            1. 5.3.5.4.2.1 By Component (Sensors and Receivers)

        5. 5.3.5.5 South Africa (Value and Volume, 2016 - 2026)

          1. 5.3.5.5.1 Self-monitoring Blood Glucose Devices

            1. 5.3.5.5.1.1 By Component (Glucometer Device, Test strips, and Lancets)

          2. 5.3.5.5.2 Continuous Glucose Monitoring

            1. 5.3.5.5.2.1 By Component (Sensors and Receivers)

        6. 5.3.5.6 Rest of Middle-East and Africa (Value and Volume, 2016 - 2026)

          1. 5.3.5.6.1 Self-monitoring Blood Glucose Devices

            1. 5.3.5.6.1.1 By Component (Glucometer Device, Test strips, and Lancets)

          2. 5.3.5.6.2 Continuous Glucose Monitoring

            1. 5.3.5.6.2.1 By Component (Sensors and Receivers)

  6. 6. MARKET INDICATORS

    1. 6.1 Type-1 Diabetes population (2016 - 2026)

    2. 6.2 Type-2 Diabetes population (2016 - 2026)

  7. 7. COMPETITIVE LANDSCAPE

    1. 7.1 COMPANY PROFILES

      1. 7.1.1 Abbott Diabetes Care

      2. 7.1.2 Roche Holding AG

      3. 7.1.3 LifeScan

      4. 7.1.4 Dexcom Inc.

      5. 7.1.5 Medtronic PLC

      6. 7.1.6 Arkray Inc.

      7. 7.1.7 Ascensia Diabetes Care

      8. 7.1.8 Agamatrix Inc.

      9. 7.1.9 Bionime Corporation

      10. 7.1.10 Acon Laboratories Inc.

      11. 7.1.11 Medisana AG

      12. 7.1.12 Trivida Functional Medicine

      13. 7.1.13 Rossmax International Ltd

      14. 7.1.14 Senseonics

    2. 7.2 COMPANY SHARE ANALYSIS

      1. 7.2.1 Self-monitoring Blood Glucose Devices

        1. 7.2.1.1 Abbott Diabetes Care

        2. 7.2.1.2 Roche Holding AG

        3. 7.2.1.3 LifeScan

        4. 7.2.1.4 Others

      2. 7.2.2 Continuous Glucose Monitoring Devices

        1. 7.2.2.1 Dexcom Inc.

        2. 7.2.2.2 Medtronic PLC

        3. 7.2.2.3 Abbott Diabetes Care

        4. 7.2.2.4 Others

  8. 8. MARKET OPPORTUNITIES AND FUTURE TRENDS

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

تمت دراسة سوق مراقبة نسبة الجلوكوز في الدم في الفترة من 2016 إلى 2027.

ينمو سوق مراقبة نسبة الجلوكوز في الدم بمعدل نمو سنوي مركب يبلغ 9.6٪ على مدى السنوات الخمس المقبلة.

تقدر قيمة سوق مراقبة نسبة الجلوكوز في الدم بـ 15 مليار دولار أمريكي في عام 2016.

تبلغ قيمة سوق مراقبة نسبة الجلوكوز في الدم 27 مليار دولار أمريكي في عام 2027.

تنمو أمريكا الشمالية بأعلى معدل نمو سنوي مركب خلال الفترة 2021-2026.

تمتلك أمريكا الشمالية أعلى حصة في عام 2021.

أبوت ديابيتس كير ، روش هولدينج إيه جي ، ميدترونيك بي إل سي ، ديكسكوم إنك ، لايف سكان هي الشركات الكبرى العاملة في سوق مراقبة نسبة الجلوكوز في الدم.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!